-
Alembic Pharmaceuticals Limited v. Novartis AG et al DC
- 1:17-cv-00292
- E.D. Va.
- Judge: Anthony J. Trenga +1
- Filed: 03/13/2017
- Closed: 06/13/2017
- Latest Docket Entry: 06/13/2017
- PACER
- Docket updated daily
1
Plaintiff
2
Defendants
0
Accused
Products
1
Patent-in-Suit
93
Days in
Litigation
-
Alembic Pharmaceuticals Limited v. Novartis AG et al DC
- 1:17-cv-00292
- E.D. Va.
- Judge: Anthony J. Trenga +1
- Filed: 03/13/2017
- Closed: 06/13/2017
- Latest Docket Entry: 06/13/2017
- PACER
- Docket updated daily
Cause of Action
Declaratory Judgment
Patent Invalidity
Patent Non-Infringement
Patent Non-Infringement
Market Sector
Biotech and Pharma
Referred Judge
Assigned Judge
Outcome Summary
- Patent Information
-
Validity & Enforceability
Claim | Outcome |
---|---|
All challenged claims |
Invalid
Entry 35 |
-
Infringement
Mitsubishi Tanabe Pharma Corporation
- 1 Detail
Accused Product | Patent # | Claim # | Outcome |
---|---|---|---|
Gilenya (fingolimod) capsules | US 8,324,283 B2 | All Asserted Claims |
No infringement
Entry 35
|
Novartis Ag
- 1 Detail
Accused Product | Patent # | Claim # | Outcome |
---|---|---|---|
Gilenya (fingolimod) capsules | US 8,324,283 B2 | All Asserted Claims |
No infringement
Entry 35
|